Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors

Kula S., Tunaoglu F., Olgunturk R., Gokcora N.

CANADIAN JOURNAL OF CARDIOLOGY, cilt.19, sa.4, ss.405-408, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 4
  • Basım Tarihi: 2003
  • Dergi Adı: CANADIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.405-408
  • Anahtar Kelimeler: angiotensin-converting enzyme inhibitors, atrial natriuretic peptide, rheumatic mitral regurgitation, CONGESTIVE-HEART-FAILURE, PLASMA
  • Gazi Üniversitesi Adresli: Evet

Özet

BACKGROUND: Rheumatic mitral regurgitation (MR) causes heart failure by volume overload and an increase in atrial natriuretic peptide (ANP) levels by atrial stretching. Symptoms of heart failure improve with ANP treatment. Angiotensin-converting enzyme inhibitors (ACEI) and ANP have similar effects, such as vasodilation, natriuresis and diuresis.